Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.59 |
| ▸ | MGLL | Q99685 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 5/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18844320 | 0.94 | KMT2A (0.60) | FAAHMGLLCA12CA1CA9 | |
| SCHEMBL10043076 | 0.90 | MGLL (0.78) | FAAHMGLLCA12CA1CA9 | |
| SCHEMBL19074450 | 0.89 | CA12 (0.51) | FAAHMGLLCA12CA1CA9 | |
| SCHEMBL11478927 | 0.85 | CA12 (0.67) | FAAHMGLLCA12CA1CA9 | |
| SCHEMBL370333 | 0.83 | MGLL (0.62) | MGLLCA12CA1CA9POLB | |
| SCHEMBL23220502 | 0.82 | MGLL (0.64) | FAAHMGLLPOLBLMNAKMT2A | |
| SCHEMBL30508999 | 0.79 | MGLL (0.60) | FAAHMGLLKMT2AHPGDALDH1A1 | |
| SCHEMBL22184094 | 0.78 | CA12 (0.59) | CA12CA1CA9POLBLMNA | |
| SCHEMBL22236845 | 0.76 | CA12 (0.52) | CA12CA1CA9POLBLMNA | |
| SCHEMBL6140262 | 0.75 | KMT2A (0.58) | MGLLCA12CA1CA9POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4220707-A1 | CONDUCTIVE SELF-HEALING COMPOSITE MATERIALS | Vrije Universiteit Brussel (BE) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023091578-A1 | LIQUID MOLD COMPOUNDS, REACTION PRODUCTS OF WHICH BECOME PLATABLE UPON EXPOSURE TO LASER ENERGY | HENKEL AG & CO. KGAA (DE) | 2023-05-25 | — | — | WO | disclosed |
| US-20230143277-A1 | DUAL CURE STEREOLITHOGRAPHY RESINS CONTAINING DIELS-ALDER ADDUCTS | CARBON INC (US) | 2023-05-11 | — | — | US | disclosed |
| US-20230143277-A1 | DUAL CURE STEREOLITHOGRAPHY RESINS CONTAINING DIELS-ALDER ADDUCTS | CARBON INC (US) | 2023-05-11 | — | — | US | disclosed |
| US-11643522-B2 | Polymer composition containing diarylamine-based compound | ZEON CORPORATION (JP) | 2023-05-09 | — | — | US | disclosed |
| US-11578202-B2 | Liquid compression molding encapsulants | HENKEL AG & CO. KGAA (DE) | 2023-02-14 | — | — | US | disclosed |
| US-20220185915-A1 | CURABLE COMPOSITION FOR MAKING CURED LAYER WITH HIGH THERMAL STABILITY | CANON KABUSHIKI KAISHA (JP) | 2022-06-16 | — | — | US | disclosed |
| US-20210253844-A1 | LIQUID COMPRESSION MOLDING ENCAPSULANTS | HENKEL AG & CO. KGAA (DE) | 2021-08-19 | — | — | US | disclosed |
| US-20210163674-A1 | LIQUID COMPRESSION MOLDING OR ENCAPSULANT COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2021-06-03 | — | — | US | disclosed |
| WO-2020037199-A1 | LIQUID COMPRESSION MOLDING OR ENCAPSULANT COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2020-02-20 | — | — | WO | disclosed |
| US-20170322600-A1 | COMPOSITIONS HAVING A MATRIX AND A HYDRATED SALT OF AN ACID AND A GROUP I OR II ELMENT OF THE PERIODIC TABLE DISPERSED THEREIN, AND ELECTRONIC DEVICES ASSEMBLED THEREWITH | Henkel IP & Holding GmbH (DE) | 2017-11-09 | — | — | US | disclosed |
| EP-2258356-B1 | CHEMICAL COMPOUNDS HAVING ANTIVIRAL ACTIVITY AGAINST DENGUE VIRUS AND OTHER FLAVIVIRUSES | CT INGENIERIA GENETICA BIOTECNOLOGIA (CU) | 2017-09-27 | — | — | EP | disclosed |
| US-20170183450-A1 | CATIONICALLY CURABLE BENZOXAZINE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2017-06-29 | — | — | US | disclosed |
| US-20130273796-A1 | Halogen-Free High-Tg Resin Composition And Prepreg And Laminate Fabricated By Using The Same | GUANGDONG SHENGYI SCI. TECH CO., LTD. (CN) | 2013-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11643522-B2 | Polymer composition containing diarylamine-based compound | GPX1, GPX4, GSTA1 | FAAH 2268/4885MGLL 2901/4885CA12 2223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.